ZA907870B - Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity - Google Patents
Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activityInfo
- Publication number
- ZA907870B ZA907870B ZA907870A ZA907870A ZA907870B ZA 907870 B ZA907870 B ZA 907870B ZA 907870 A ZA907870 A ZA 907870A ZA 907870 A ZA907870 A ZA 907870A ZA 907870 B ZA907870 B ZA 907870B
- Authority
- ZA
- South Africa
- Prior art keywords
- carboxytetrahydroisoquinolines
- derivatives
- substituted
- pharmaceutical activity
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4021—Esters of aromatic acids (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41668489A | 1989-10-03 | 1989-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA907870B true ZA907870B (en) | 1992-06-24 |
Family
ID=23650893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA907870A ZA907870B (en) | 1989-10-03 | 1990-10-02 | Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0421436A3 (no) |
JP (1) | JPH03120254A (no) |
KR (1) | KR910007885A (no) |
AU (1) | AU6368090A (no) |
CA (1) | CA2026680A1 (no) |
FI (1) | FI904838A0 (no) |
IE (1) | IE903528A1 (no) |
NO (1) | NO904285L (no) |
PT (1) | PT95487A (no) |
ZA (1) | ZA907870B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
DE4104257A1 (de) * | 1991-02-13 | 1992-08-20 | Boehringer Ingelheim Kg | Verwendung von anellierten tetrahydropyridinessigsaeurederivaten fuer die behandlung neurologischer erkrankungen |
DE19605766A1 (de) * | 1996-02-16 | 1997-08-21 | Basf Ag | Substituierte 2-Phenylpyridine |
CA2259431A1 (en) * | 1996-07-01 | 1998-01-08 | Eli Lilly And Company | Hypoglycemic and hypolipidemic compounds |
AU5959201A (en) | 2000-05-11 | 2001-11-20 | Bristol Myers Squibb Co | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
US6649606B1 (en) | 2001-11-09 | 2003-11-18 | Bristol-Myers Squibb Co. | Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity |
ZA200701232B (en) | 2004-07-15 | 2008-08-27 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
US20100024089A1 (en) | 2008-08-01 | 2010-02-04 | Nike, Inc. | Apparel With Selectively Attachable And Detachable Elements |
US8898820B2 (en) | 2008-08-01 | 2014-12-02 | Nike, Inc. | Layered apparel with attachable and detachable elements |
US10499694B2 (en) | 2008-08-01 | 2019-12-10 | Nike, Inc. | Apparel with selectively attachable and detachable elements |
CA2760837C (en) | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
WO2010132437A1 (en) | 2009-05-12 | 2010-11-18 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
JP5739415B2 (ja) | 2009-05-12 | 2015-06-24 | ブリストル−マイヤーズ スクウィブ カンパニー | (S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8801491D0 (en) * | 1988-01-22 | 1988-02-24 | Beecham Group Plc | Novel compounds |
CA2000901A1 (en) * | 1988-10-21 | 1990-04-21 | Alexis A. Cordi | Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury |
-
1990
- 1990-09-28 AU AU63680/90A patent/AU6368090A/en not_active Abandoned
- 1990-09-29 KR KR1019900015867A patent/KR910007885A/ko not_active Application Discontinuation
- 1990-10-01 FI FI904838A patent/FI904838A0/fi not_active Application Discontinuation
- 1990-10-02 ZA ZA907870A patent/ZA907870B/xx unknown
- 1990-10-02 CA CA002026680A patent/CA2026680A1/en not_active Abandoned
- 1990-10-02 NO NO90904285A patent/NO904285L/no unknown
- 1990-10-02 PT PT95487A patent/PT95487A/pt not_active Application Discontinuation
- 1990-10-02 IE IE352890A patent/IE903528A1/en unknown
- 1990-10-02 JP JP2263276A patent/JPH03120254A/ja active Pending
- 1990-10-04 EP EP19900119077 patent/EP0421436A3/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
IE903528A1 (en) | 1991-04-10 |
JPH03120254A (ja) | 1991-05-22 |
KR910007885A (ko) | 1991-05-30 |
NO904285D0 (no) | 1990-10-02 |
NO904285L (no) | 1991-04-04 |
AU6368090A (en) | 1991-04-11 |
CA2026680A1 (en) | 1991-04-04 |
PT95487A (pt) | 1991-08-14 |
EP0421436A3 (en) | 1992-03-11 |
FI904838A0 (fi) | 1990-10-01 |
EP0421436A2 (en) | 1991-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0428268A3 (en) | Pharmaceutical phenylpyridone derivatives | |
NZ233320A (en) | 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions | |
NZ236625A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
NZ233790A (en) | Benzocycloalkane derivatives and pharmaceutical compositions | |
NZ228098A (en) | Quinoline derivatives and pharmaceutical compositions | |
NZ227743A (en) | Isoquinolinone derivatives and their pharmaceutical compositions | |
EP0421436A3 (en) | Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity | |
NZ233011A (en) | Thieno-triazole-diazepine and pharmaceutical compositions | |
NZ225613A (en) | Benzazepin-2-one derivatives and pharmaceutical compositions | |
NZ233013A (en) | Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions | |
AR243886A1 (es) | Proceso para la preparacion de derivados de 2-carboxamido-tiofeno. | |
GB8906129D0 (en) | Pharmaceutical preparations | |
ZA906186B (en) | Pharmaceutical preparations | |
NZ228281A (en) | Tricyclo-amine derivatives and pharmaceutical compositions | |
NZ230921A (en) | 3-phenyloxymethyl-cephalosporin derivatives and medicaments | |
AU5061990A (en) | Azacyclooctadiene compound and pharmaceutical use | |
CS343490A3 (en) | Pharmaceutical | |
GB8830405D0 (en) | Pharmaceutical formulation | |
NZ236574A (en) | Phenylsulphonamide derivatives and pharmaceutical compositions thereof | |
IL92606A0 (en) | Sphingenine and derivatives thereof | |
NZ231558A (en) | Benzenesulphonamide derivatives and pharmaceutical compositions thereof | |
HU9601069D0 (en) | Benzimidazol derivatives and pharmaceutical compozitions containing them | |
ZA901443B (en) | Aminoethylthiazole and aminoethyloxazole derivatives | |
IE881376L (en) | Anti-malarial pharmaceutical combination | |
GB8900228D0 (en) | Pharmaceutical use |